Vav1 Regulates T-Cell Activation through a Feedback Mechanism and Crosstalk between the T-Cell Receptor and CD28

被引:25
|
作者
Helou, Ynes A. [1 ]
Petrashen, Anna P. [2 ]
Saolomon, Arthur R. [2 ]
机构
[1] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02903 USA
[2] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02903 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
phosphoproteomics; T cell receptor signaling; mass spectrometry; Vav1; TYROSINE PROTEIN-KINASE; EXCHANGE FACTOR VAV; PHOSPHATIDYLINOSITOL; 3-KINASE; ANTIGEN-RECEPTOR; RHO-FAMILY; PHOSPHOLIPASE C-GAMMA-1; PROTOONCOGENE PRODUCT; PHOSPHORYLATION SITES; SIGNALING PATHWAYS; CYTOPLASMIC TAIL;
D O I
10.1021/acs.jproteome.5b00340
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Vav1, a Rac/Rho guanine nucleotide exchange factor and a critical component of the T-cell receptor (TCR) signaling cascade is tyrosine phosphorylated rapidly in response to T-cell activation. Vav1 has established roles in proliferation, cytokine secretion, Ca2+ responses, and actin cytoskeleton regulation; however, its function in the regulation of phosphorylation of TCR components, including the zeta chain, the CD3 delta, epsilon, gamma chains, and the associated kinases Lck and ZAP-70, is not well established. To obtain a more comprehensive picture of the role of Vavl in receptor proximal sighaling, we performed a wide-scale characterization of Vavl-dependent tyrosine phosphorylation events using quantitative phosphoproteomic analysis of VavI-deficient T cells across a time course of TCR stimulation. Importantly, this study revealed a new function for Vav1 in the negative feedback regulation of the phosphorylation of immunoreceptor tyrosine-based activation motifs within the chains, CD3 delta, epsilon, gamma chains, as well as activation sites on the critical T cell tyrosine kinases Itk, Lck, and ZAP-70. Our study also uncovered a previously unappreciated role for Vavl in crosstalk between the CD28 and TCR signaling pathways.
引用
收藏
页码:2963 / 2975
页数:13
相关论文
共 50 条
  • [1] Monocyte: T-cell interaction regulates human T-cell activation through a CD28/CD46 crosstalk
    Charron, Lauren
    Doctrinal, Axelle
    Choileain, Siobhan Ni
    Astier, Anne L.
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2015, 93 (09): : 796 - 803
  • [2] CD28 AND T-CELL ACTIVATION
    OLIVE, D
    VANLIER, R
    [J]. RESEARCH IN IMMUNOLOGY, 1995, 146 (03): : 127 - 129
  • [3] ROLE OF THE CD28 RECEPTOR IN T-CELL ACTIVATION
    JUNE, CH
    LEDBETTER, JA
    LINSLEY, PS
    THOMPSON, CB
    [J]. IMMUNOLOGY TODAY, 1990, 11 (06): : 211 - 216
  • [4] T-CELL COSTIMULATION THROUGH THE CD28 RECEPTOR
    GREEN, IM
    NOEL, PJ
    SPERLING, AI
    WALUNAS, TL
    LENSCHOW, DJ
    STACK, R
    GRAY, GS
    BLUESTONE, JA
    THOMPSON, CB
    [J]. PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1995, 107 (01) : 41 - 46
  • [5] CD28 AND T-CELL ACTIVATION - DISCUSSION
    LEDBETTER, J
    LINSLEY, P
    LANE, P
    RUDD, CE
    SCHNEIDER, H
    SOMOZA, C
    LANIER, LL
    VANGOOL, SW
    CEUPPENS, JL
    DEBOER, M
    CHIODETTI, L
    SCHWARTZ, RH
    [J]. RESEARCH IN IMMUNOLOGY, 1995, 146 (03): : 197 - 205
  • [6] The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
    Riley, JL
    June, CH
    [J]. BLOOD, 2005, 105 (01) : 13 - 21
  • [7] Cbl-b regulates the CD28 dependence of T-cell activation
    Chiang, YPJ
    Kole, HK
    Brown, K
    Naramura, M
    Fukuhara, S
    Hu, RJ
    Jang, IK
    Gutkind, JS
    Shevach, E
    Gu, H
    [J]. NATURE, 2000, 403 (6766) : 216 - 220
  • [8] Cbl-b regulates the CD28 dependence of T-cell activation
    Yungping J. Chiang
    Hemanta K. Kole
    Karen Brown
    Mayumi Naramura
    Shigetomo Fukuhara
    Ren-Ju Hu
    Ihn Kyung Jang
    J. Silvio Gutkind
    Ethan Shevach
    Hua Gu
    [J]. Nature, 2000, 403 : 216 - 220
  • [9] 100 inhibits T-cell function through suppressing Vav1 expression and activation
    Ren, Xiubao
    [J]. CANCER RESEARCH, 2009, 69
  • [10] IDO inhibits T-cell function through suppressing Vav1 expression and activation
    Li, Runmei
    Wei, Feng
    Yu, Jinpu
    Li, Hui
    Ren, Xiubao
    Hao, Xishan
    [J]. CANCER BIOLOGY & THERAPY, 2009, 8 (14) : 1402 - 1408